Name | 2-cyano-3-(3,4-dihydroxyphenyl)-N-phenylprop-2-enamide |
---|---|
Synonyms |
Tyrphostin 48
2-Propenamide, 2-cyano-3-(3,4-dihydroxyphenyl)-N-phenyl-, (2E)- HMS3266B19 (2E)-2-Cyano-3-(3,4-dihydroxyphenyl)-N-phenylacrylamide AG-494 |
Description | AG-494 (Tyrphostin AG 494) is a potent and selective EGFR tyrosine kinase inhibitor (IC50=0.7 μM). AG-494 inhibits the autophosphorylation of EGFR, ErbB2, HER1-2 and PDGF-R with IC50s 1.1, 39, 45 and 6 μM, respectively. AG-494 blocks Cdk2 activation and inhibits EGF-dependent DNA synthesis[1][2][3]. |
---|---|
Related Catalog | |
Target |
EGFR:0.7 μM (IC50) |
In Vitro | In DHER-14 cells, AG 494 inhibits Cdk2 activation and EGF-dependent DNA synthesis[2]. AG-494 significantly prevents NF-kB activation in silica-stimulated cells, and also reduces NF-kB activation in H2O2-treated cells[4]. AG-494 (3-9 μM; 5-7 days) inhibits BMP9-induced ALP activity in a dose-dependent manner[5]. |
References |
[2]. Osherov N, et al. Tyrphostin AG 494 blocks Cdk2 activation. FEBS Lett. 1997;410(2-3):187-190. |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 586.9±50.0 °C at 760 mmHg |
Melting Point | 249 °C(dec.) |
Molecular Formula | C16H12N2O3 |
Molecular Weight | 280.278 |
Flash Point | 308.8±30.1 °C |
Exact Mass | 280.084778 |
PSA | 93.35000 |
LogP | 2.40 |
Vapour Pressure | 0.0±1.7 mmHg at 25°C |
Index of Refraction | 1.736 |